Biosimilars Research: Awards
Similar Posts
Gilead Issues Voluntary Nationwide Recall of One Lot of Veklury (Remdesivir) for Injection 100 mg/vial Due to the Presence of a Glass Particle
Foster City, Calif., September 20, 2024 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced it is issuing a voluntary recall of one lot of Veklury® (remdesivir) for Injection 100 mg/vial, to the consumer level. Gilead received a customer complaint and confirmed the presence of a glass particle inFrequently Asked Questions about Drug Shortages
This page answers frequently asked questions (FAQ) about drug shortages such as what is a drug shortage, how many per year, how the FDA addresses and takes action on shortages, how the FDA notifies the public, what manufacturers are supposed to report to the FDA, and reasons for many drug shortagesInfusion Pump Correction: ICU Medical, Inc. Issues Correction for Plum Duo Infusion System Due to Software Possibly Resulting in Pump Becoming Unresponsive
ICU Medical is correcting the Plum Duo infusion system due to pump software issues that may cause the device to become unresponsive.User Fee Lists
GDUFA User Fee ListsPharmathen International S.A.11/21/2025 483
Pharmathen International S.A. 11/21/2025 483Columbia Cosmetics Manufacturing Inc. – 710885 – 09/11/2025
CGMP/Finished Pharmaceuticals/Adulterated